Dimensioni, segmenti e analisi del mercato delle terapie antisenso e RNAi entro il 2025-2031
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Tipo
- Interferenza dell'RNA
- RNA antisenso
By Via di somministrazione
- somministrazione polmonare
- iniezioni endovenose
- intradermica
- intraperitoneale
- topica
- altre
By Applicazione
- Malattie infettive
- Malattie cardiovascolari
- Cancro
- Disturbi neurologici
- Altri
By Geografia
- Nord America
- Europa
- Asia-Pacifico
- Sud e Centro America
- Medio Oriente e Africa
Get Free Sample For